NWIS are looking to procure an all Wales (SACT) ePrescribing Solution. SACT encompasses both biological therapy and cytotoxic chemotherapy (a group of medicines containing chemicals directly toxic to cells preventing their replication or growth). SACT, including chemotherapy, has been provided in the NHS for decades but no national recording of treatment has previously existed, this is therefore a new approach to service delivery. NWIS will be hosting a supplier engagement day on 10.10.2019, the agenda will be confirmed in due course, allowing NWIS to engage with the market and understand what products/solutions are now available. We anticipate the day to include an NWIS overview of the requirements, followed by breakout sessions with individual suppliers to discuss their specific solutions. Following the day, NWIS will develop a scoping document that will be issued to suppliers requesting them to respond with indicative costs that will be used to inform our business case.